Skip to main content
. Author manuscript; available in PMC: 2012 Feb 29.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Oct;55(2):189–196. doi: 10.1097/QAI.0b013e3181e46308

Figure 1.

Figure 1

Neutralizing antibody (MN) responses to LAIV and TIV in HIV-infected children on HAART. Data were derived from 234 HIV-infected children randomly assigned to receive LAIV or TIV during the 2004–2005 influenza season. Bars represent geometric mean titers (GMT) and 95% CI. Baseline values were similar in both treatment groups. MN titers were significantly higher in TIV compared with LAIV recipients at weeks 4 and 24 for all strains except for A H1N1 New Caledonia at week 24 (F test).